Concord Biotech Share Price

ABOUT Concord Biotech

• ISIN INE338H01029
• BSE Code 543960
• NSE Code CONCORDBIO

Concord Biotech Limited is an India-based research and development driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. The Company manufactures active pharmaceutical ingredients (API) through fermentation and semi-synthetic process and finished formulations. The Company’s offerings span both bio-pharmaceutical APIs and formulations across therapeutic areas like immunosuppressants oncology, anti-infectives nephrology, and critical care. Its portfolio also includes fermentation-based APIs in anti-bacterial, anti-fungal, and other therapeutic segments. Its API products include Mycophenolate Mofetil, Mycophenolate Sodium, Cyclosporine, Sirolimus, Pimecrolimus, Voclosporin, Mupirocin, Mupirocin Calcium, Vancomycin Hydrochloride, Teicoplanin, Polymyxin B Sulfate, Fidaxomicin, Anidulafungin. Its API products under development include Daptomycin, Epirubicin, Idarubicin, and Pirarubicin.

MANAGEMENT

• Sudhir Vaid Executive Chairman of the Board, Managing Director
• Ankur Vaid Chief Executive Officer, Joint Managing Director, Executive Director
• Lalit Sethi Chief Financial Officer
• Prakash Sajnani Compliance Officer, Company Secretary, Assistant Vice President - Finance
• Devang Bhatt Vice President - Sales and Marketing, Head - Limbasi Plant - 3
• Manoj Kumar Vice-President - Formulation Division and Head - Valthera Unit - 2
• Sundeep Bengani General Manager - International Business Development, Formulation Division